ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 307

Abnormal Imaging and Increased Osteoclast Precursors In a Psoriasis Cohort Are Associated with New Onset of Psoriatic Arthritis

Ralf G. Thiele1, Yahui Grace Chiu1, Francisco A. Tausk2, Bethany A. Marston1, Gregory Dieudonne3, Vaseem Chengazi3, Michelle Smith1, Sharon Moorehead1, Rick Barrett1 and Christopher T. Ritchlin1, 1Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY, 2Dermatology, University of Rochester, Rochester, NY, 3Radiology, University of Rochester, Rochester, NY

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Biomarkers, Imaging, osteoclasts, Psoriatic arthritis and ultrasound

  • Tweet
  • Email
  • Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment: Psoriatic Arthritis: Clinical Aspects and Treatment I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Psoriasis (Ps) precedes joint inflammation by about 10 years in patients who develop psoriatic arthritis (PsA). Several studies have documented abnormal musculoskeletal imaging findings and we found elevated osteoclast precursor (OCP) frequency in Ps patients without musculoskeletal signs or symptoms. The association of imaging abnormalities and OCP frequency with arthritis onset in a prospective psoriasis cohort, however, has not been examined.

Methods:

Ps patients with > 5 years of psoriasis or >10% body surface area (any disease duration) were enrolled if they scored less than 36 on the Psoriatic Arthritis Screening and Evaluation (PASE) questionnaire and showed no active arthritis or enthesitis on rheumatologic exam. All patients were imaged with a 3-phase bone scan and Power Doppler Ultrasound (PDUS) of joints and entheses. If the bone scan revealed evidence of inflammation, a gadolinium enhanced 3T MRI was performed on the joint with the highest scintigraphy signal. All imaging studies were analyzed by 2 radiologists. A diagnosis of PsA was confirmed by the CASPAR criteria on follow-up annual exams. Blood samples were drawn for OCP quantification after 8-day cell culture.

Results:

39 Ps patients (44% female) were enrolled with a mean age 45±6 years, disease duration 15±2 years, BMI 30±3 kg/m2 and PASI score 9±2. Eleven subjects had normal studies, 8 had active joint inflammation on imaging but remained asymptomatic but 5 additional subjects with baseline imaging abnormalities subsequently developed PsA. Thirteen patients showed evidence of active or prior enthesitis (calcification at insertions) on imaging. Two patients had active tenosynovitis and 1 patient had plantar fasciitis. The patients were categorized into 4 subsets based on the imaging analysis and/or clinical features: (1) no imaging abnormality, n=11; (2) joint inflammation (imaging) without clinical symptoms, n=8; (3) development of PsA, n=5; (4) enthesitis or entheseal calcification, n=13. The OCP frequency was examined in cultured PBMC or purified monocytes isolated from these 4 patient subsets (Table 1).

(1) Normal

(2) Imaging Arthritis

(3) PsA

(4) Enthesitis

PBMC

9 ± 9.3

140 ± 141

316± 267

64 ± 49

Monocytes

168 ± 96

1,209± 492

1,273± 549

467 ± 231

Table 1. OCP frequency in 4 cohorts of Ps patients categorized by imaging results (mean+SEM).

Conclusion:

Among 39 Ps patients monitored for 3 months to 3 years, 8 patients showed baseline imaging abnormalities but remained asymptomatic; 5 patients with imaging abnormalities subsequently developed PsA, and 13 patients had acute or chronic entheseal signals. The OCP frequency was highest in patients with new onset PsA and inflammation on imaging studies. These results demonstrate the high prevalence of subclinical joint inflammation and entheseal changes in Ps and provide evidence that elevated OCP frequency may serve as a surrogate marker for joint inflammation and risk for arthritis in Ps patients.


Disclosure:

R. G. Thiele,
None;

Y. G. Chiu,
None;

F. A. Tausk,
None;

B. A. Marston,
None;

G. Dieudonne,
None;

V. Chengazi,
None;

M. Smith,
None;

S. Moorehead,
None;

R. Barrett,
None;

C. T. Ritchlin,

Amgen, Janssen, UCB, Abbott, Boerhinger Ingleheim, Lilly, ,

5.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/abnormal-imaging-and-increased-osteoclast-precursors-in-a-psoriasis-cohort-are-associated-with-new-onset-of-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology